Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,616 GBX | -0.77% | +0.91% | +11.19% |
09:40am | GSK gets FDA approval for Arexvy vax in 50-59 year olds at risk of RSV | AN |
09:39am | GSK: FDA approves vaccine against respiratory virus | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+11.19% | 84.52B | |
+45.82% | 765B | |
-6.16% | 354B | |
+19.86% | 331B | |
+9.32% | 299B | |
+18.81% | 248B | |
-1.31% | 219B | |
+11.19% | 216B | |
+5.90% | 164B | |
-0.73% | 162B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Top Midday Stories: CVS Reports Q1 Earnings Miss, Lowers Outlook; ADP Q1 Earnings Top Estimates; J&J Proposes $6.5 Billion Settlement for Talc Lawsuits